A devastating measles outbreak in Bangladesh has claimed the lives of more than 1,000 children and infected over 187,000 people since mid-March, overwhelming healthcare facilities and triggering widespread economic hardship for affected families. The crisis, concentrated among young children, has exposed significant gaps in the country’s public health response.

The outbreak’s toll is illustrated by the experience of Roman Pathan and his wife, Zakia Sultana, whose seven-month-old daughter, Rokeya Jannat, succumbed to the disease in April at the Infectious Diseases Hospital (IDH) in Dhaka. Rokeya’s illness began with pneumonia treated at local hospitals before progressing to severe measles symptoms that required advanced care. Her death highlights a broader systemic issue: many patients are transferred between multiple healthcare facilities due to a shortage of critical care resources outside the capital, often arriving for specialized treatment only when severely ill.

Since the outbreak began on March 15, more than 147,000 measles patients have required hospitalization, straining local health infrastructure. Families have faced considerable financial distress in covering medical costs, frequently resorting to borrowing money or selling assets. The economic impact has compounded the public health emergency, forcing many into cycles of debt.

The government has placed primary responsibility for the outbreak on the previous interim administration led by Nobel laureate Prof Muhammad Yunus, citing failures to procure vaccines on time and delays in implementing a much-needed vaccination campaign despite UNICEF’s warnings. Health Minister Sardar Md Sakhawat Husain accused the former leadership of neglecting critical vaccine shortages and stalling immunization efforts.

However, public health experts argue that the current government also bears accountability for the outbreak’s severity. While an emergency measles-rubella vaccination campaign was launched on April 5 and reportedly exceeded its initial target by vaccinating 18.4 million children aged six to 59 months by May 20, a subsequent nationwide Vitamin A Plus campaign in late June revealed significant data discrepancies. The second campaign reached over 22 million children in the same age group, suggesting nearly 3.9 million eligible children were missed during the initial drive.

The resulting delay necessitated a mop-up vaccination effort starting in late July, but infections, hospital admissions, and deaths rose again in August. Experts such as Mushtuq Husain, a former principal scientific officer at the Institute of Epidemiology, Disease Control and Research, have criticized the government’s emphasis on tertiary care facilities at the expense of early detection, patient management, hygiene practices, and contact tracing—all essential components in containing highly contagious diseases like measles.

Husain emphasized that reducing fatalities requires strengthening healthcare responses at primary and secondary levels to intercept cases before they advance to intensive care. He also noted the absence of a comprehensive pandemic-style strategy, which contributed to unchecked transmission and inadequate patient support.

Despite these criticisms, Health Minister Sakhawat dismissed allegations of mismanagement, asserting that the government had deployed mobile hospitals, adhered to treatment protocols, and adequately provided hospital beds. He acknowledged that measles has struck Bangladesh with an unprecedented intensity, raising speculation about a possible new viral variant, though none has been identified.

Looking ahead, the government plans to initiate a new, full-scale measles vaccination campaign starting September 25. The drive will target infants aged six months and older, including those missed in prior efforts, in an effort to address the low levels of herd immunity driving ongoing infections. According to officials, the majority of current measles patients are unvaccinated, underscoring the urgent need to reach vulnerable populations and prevent further loss of life.